Filing Details

Accession Number:
0001209191-14-019959
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-12 19:00:20
Reporting Period:
2014-03-10
Filing Date:
2014-03-12
Accepted Time:
2014-03-12 18:00:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302103 L Andrew Finn C/O Biodelivery Sciences Intl, Inc.
801 Corporate Center Drive, Suite 210
Raleigh NC 27607
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-10 14,150 $9.94 726,300 No 4 S Direct
Common Stock Disposition 2014-03-11 65,850 $10.00 660,450 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale of the shares of common stock was made pursuant to a pre-planned 10b5-1 plan.
  2. On March 11, 2014, the Reporting Person sold an aggregate of 65,850 shares of the Issuer's Common Stock at a weighted average price of $10.00. The highest sale price for the Common Stock was $10.10 per share and the lowest sale price was $9.94 per share.